Ejiao alleviates sarcopenia by AKT/mTOR/Foxo3a and AMPK pathways in an aging rat model induced by D-Galactose combined with restricted movement
These findings suggest that Ejiao significantly improves muscle function and provides a promising avenue for sarcopenia treatment, highlighting its potential as a novel therapeutic candidate.
Authors
- Jie Cheng (ORCID: https://orcid.org/0000-0001-9972-2166)
- Guanhua Du (ORCID: https://orcid.org/0000-0002-6896-0847)
- Hongwei Zhang (ORCID: https://orcid.org/0000-0002-1636-2204)
- Zhengjuan Li
- Qin Feng (ORCID: https://orcid.org/0000-0002-4641-1636)
- Xiaoying Zhou (ORCID: https://orcid.org/0000-0002-7901-2842)
- Chuyi Liu (ORCID: https://orcid.org/0000-0001-5092-9799)
- Lili Zhao (ORCID: https://orcid.org/0000-0002-6366-8206)
- Xiaobo Duan (ORCID: https://orcid.org/0000-0001-6963-8967)
- Shan Liu
- Yue Zhang (ORCID: https://orcid.org/0000-0002-3563-0673)
- Juan Wu (ORCID: https://orcid.org/0000-0001-6640-6335)
- Haibin Liu (ORCID: https://orcid.org/0000-0002-8267-8717)
- Mingchao Yv
Institutions
- General Electric (Spain) (ES)
- Eulji University (KR)
- Marine Biomedical Research Institute of Qingdao (CN)
- Ocean University of China (CN)
Publication Details
- Journal
- Journal of Ethnopharmacology
- Published
- 2025-10-28
- DOI
- https://doi.org/10.1016/j.jep.2025.120819
- Primary Topic
- Antioxidants, Aging, Portulaca oleracea
- Type
- article
- Field-Weighted Citation Impact
- 0.00